Belgium – Antibacterials for systemic use – ANTI-INFECTIEUX 2026-2030
Opportunity Score
Confidence: 70%
Complexity: high
29 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
This tender is a 4-year framework agreement for the supply of anti-infective drugs (antibacterials) to HUmani SC and CHU Charleroi-Chimay in Belgium. It is divided into 49 lots, each corresponding to a specific drug (e.g., Aciclovir injectable). The contract runs from December 2026 to November 2030. Submission is electronic via eTendering, with a deadline of July 14, 2026. Award criteria are 55% cost and 45% quality. Strict minimum annual turnover requirements apply per lot, cumulative if bidding for multiple lots.
Strengths
Documents available
Open procedure
29 days left
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Framework agreement with a single operator per lot
- Electronic submission required via Open portal
- Tenders must be in French
Buyer
Name
HUmani SC
Location
Charleroi, BEL
Website
Identifier
BE 216.377.108.
Lots (49)
Supply of injectable Aciclovir
Supply of antibacterials – detailed product not specified in data
Supply of antibacterials – detailed product not specified in data
Procurement Details
Publication
11 Jun 2026
Deadline
14 Jul 2026, 08:30
Procedure
open
Contract
supplies
Language
FRA
Publication #
406055-2026
Classification
Performance: Belgium
Documents (2)
Opportunity Score
Confidence: 70%
Complexity: high
29 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation